Company may withdraw single-dose rubella vaccine

The Glaxo SmithKline pharmaceutical company is expected to withdraw a single-dose rubella vaccine from the Irish market.

The company has already halted production of Ervevax in Britain and is expected to make a decision regarding its distribution in Ireland by the end of next week.